Loading…
Loading…

| JNJ | Johnson & Johnson | $275.23 | $663.3B |
| ABBV | AbbVie Inc. | $256.34 | $452.9B |
| MRK | Merck & Co., Inc. | $150.34 | $371.3B |
| NVS | Novartis AG | $159.99 | $304.1B |
| AZN | AstraZeneca PLC | $162.70 | $252.3B |
| AMGN | Amgen Inc. | $437.23 | $236.0B |
| NVO | Novo Nordisk A/S | $46.60 | $206.9B |
| GILD | Gilead Sciences, Inc. | $151.00 | $187.5B |
| PFE | Pfizer Inc. | $28.45 | $162.1B |
| SNY | Sanofi | $44.24 | $106.2B |